Facilities in the School of Cancer Medicine
The Olivia Newton-John Cancer Research Institute (ONJCRI), affiliated with La Trobe University as the School of Cancer Medicine, is home to over 4,100 square metres of laboratories, and offers state-of-the-art platform technologies and world-class expertise.
Our research platforms are purpose-built to support a range of advanced technologies and techniques, from cutting-edge microscopy to advanced gene editing, to empower researchers, to accelerate discoveries and deliver real-world impact.
They also give students an opportunity to expand their skillset beyond classic research techniques at the bench.
Our facilities include:
This is a leading facility for target and drug discovery and clinical translation, using state-of-the-art molecular imaging and theranostic techniques, where imaging is matched with radiopharmaceutical therapy.
The capabilities of this platform include radiolabelling, pharmaceutical compound performance analysis and translation of discoveries into potential treatments.
This facility is equipped with cutting-edge microscopy and spatial proteomics technologies, along with instrumentation and analytical systems.
It is home to one of the most advanced multiphoton microscopy platforms in Victoria.
The Centre is committed to advancing our understanding of how tumours interact with and corrupt normal cells, and alter the surrounding microenvironment at the cellular and molecular levels.
This facility is a state-of-the-art shared resource offering comprehensive analytical cytometry and high-speed cell sorting services to our researchers and collaborators.
It delivers high-quality services and proactively integrates flow cytometry into our diverse research programs. The technologies provide our researchers with automated and accurate cell sorting, sample processing, custom assays and analysis.
This facility specialises in advanced CRISPR gene-editing technologies to generate preclinical models of human disease by using advanced CRISPR/Cas technology alongside precise microinjection techniques.
To date, the Centre has successfully created over 400 unique gene-edited preclinical models, playing a critical role in advancing both fundamental biological research and translational studies.
Supported by the National Imaging Facility, this facility offers cutting-edge technologies for non-invasive imaging using PET, SPECT or IVIS systems, CT and 3T MRI scanners.
This platform is advancing RNA therapeutics through precision-engineered lipid nanoparticle delivery systems.
It provides state-of-the-art technologies for the design, assembly and characterisation of next-generation nucleic acid delivery systems.
Collaborate with us
Whether you’re advancing your next big idea or looking to partner on transformative research, we invite you to collaborate with us as we push the frontiers of science to improve the future of health and medicine.